Retatrutide (10mg)

Retatrutide is a next-generation GLP-1, GIP and Glucagon receptor agonist designed for advanced metabolic research. Its multi-pathway activation profile allows researchers to explore complex metabolic signalling with far greater depth than single-agonist compounds.

This triple-receptor activity has made Retatrutide a popular choice in studies investigating metabolic regulation, energy balance and obesity-related mechanisms.

Key Features

• Research grade, high-purity peptide
• Strong receptor affinity across GCGR, GLP-1R and GIPR
• Manufactured under cGMP conditions
• Batch-specific COA supplied
• Long-term stability when stored correctly

Research Applications

• Metabolic regulation studies
• Weight-related mechanism exploration
• Glucose and lipid pathway investigation
• Comparative analyses against single-agonist peptides

Retatrutide offers researchers a valuable tool for examining how multiple metabolic pathways interact and influence one another.

For laboratory research use only. Not for human consumption.